Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Given the risk of miscarriage, pregnant women should not use ashwagandha
1 The study details 800 participants in the interim analysis (1,197 total enrolled) with biopsy-confirmed MASH and moderate to severe fibrosis (stage F2 or F3) Participants were randomly assigned to receive semaglutide 2.4 mg weekly or placebo Treatment lasted 72 weeks 2:1 randomisation (534 semaglutide, 266 placebo) Resolution of MASH (primary outcome) Fibrosis improvement (primary outcome) Combined outcomes About a third (32.7%) of participants taking semaglutide achieved both MASH resolution and fibrosis improvement, compared to 16.1% on placebo
FDA, Multiple Endpoints in Clinical Trials: Guidance for Industry, Technical Report, U.S
Short-term: room temperature is fine, briefly Dry powder tolerates room temperature for days to weeks, such as during shipping
